Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1994
The purpose of this study is to evaluate the efficacy and safety of mometasone furoate (SCH 32088) aqueous nasal spray 200 mcg once daily compared to placebo once daily in the treatment of participants with seasonal allergic rhinitis. Flonase (fluticasone propionate) nasal spray 200 mcg once daily has been chosen as the active control for this study.
Epistemonikos ID: 803cebbfeb8e170dd5ac2c9c1020f353d9ef3a2a
First added on: May 22, 2024